30 likes | 43 Views
The extraordinarily growing prevalence of cancers worldwide is likely to be the leading factor pushing demand for gene expression analysis. It also has been working to the advantage of the field of personalised medicine. While cancer therapeutics and research continue to garner funds, and investments from across the globe, a wide range of sequencing procedures are also gaining stronger ground u2013 majorly on the back of their consistently falling costs.
E N D
The research community has been attracting huge government investments as the significance of genomics continues to grow worldwide. Global gene expression market is predominantly driven by the notable developments in genomic databases, says a new research intelligence study of Fairfield Market Research. The report highlights that with the advent of next-generation sequencing (NGS) techniques, demand for gene expression analysis also continues to be on an upswing. Besides the critically soaring need for effective carcer therapeutics, rising boom around personalised medicine, and an increasing number of genetic conditions being diagnosed will largely contribute toward the expansion of gene expression market. Gene expression analysis also gained overnight traction amid COVID-19 risk factor detection as a vital step of disease diagnostics. Looking For a Sample Copy of This Report? Request the Same Here: https://www.fairfieldmarketresearch.com/report/gene-expression-market/request- sample Demand for Gene Expression Analysis Surges as Cancer Research and Therapeutics Take the Limelight The extraordinarily growing prevalence of cancers worldwide is likely to be the leading factor pushing demand for gene expression analysis. It also has been working to the advantage of the field of personalised medicine. While cancer therapeutics and research continue to garner funds, and investments from across the globe, a wide range of sequencing procedures are also gaining stronger ground – majorly on the back of their consistently falling costs. Gene expression market is especially projected for a healthy growth outlook as gene therapy has become one of the hottest areas of research luring investors, governments, as well as medical industry alike. As the concept of precision medicine firms up, the market for gene expression is all set to reap the benefit in long run. Besides cancers, prevalence of rare
diseases, and inherited conditions continues to be on a higher side as well. This is also expected to be among the important factors strengthening gene expression market. Leading Players in Global Gene Expression Market Space Fairfield Market Research in its report would reveal some exclusive insights on the leading companies stirring the global gene expression market competition landscape. Some of the prominent players profiled in the report, include Thermo Fisher Scientific, Inc., F. Hoffmann- La Roche AG, Promega Corp., Biocartis NV, Bio-Rad Laboratories, Inc., Illumina, Inc., Agilent Technologies, QIAGEN N.V., GE Healthcare, Becton, Dickinson and Company, PerkinElmer Inc., Oxford Gene Technology, Quest Diagnostics, Inc., Luminex Corp., Takara Bio, Inc., Interpace Biosciences, Inc., and AutoGenomics. Clinical Diagnostics Holds the Promise to Unlock New Opportunities Gene expression has established itself as a sought-after technology for applications in biotechnology, drug development and discovery, microbiology, clinical diagnostics, pharmacogenomics, and toxicogenomics. While the world of medicine is continuously longing for early, and accurate detection/diagnosis, it will offer a strong impetus to the field of clinical diagnostics. This is particularly projected to raise the application potential of RNA expression analysis in clinical diagnostics, especially for rare genetic conditions in premature infants, and early-onset infections (EOIs). Advent of stem cell therapy, and genetic engineering further elevate the growth potential of gene expression market. Do You Have Any Query or Specific Requirement? Request Customization of Report: https://www.fairfieldmarketresearch.com/report/gene-expression-market/request- customization North America Continues to Lead, Market Attractiveness of Asia Pacific Soars Preliminary findings of regional analysis of gene expression market suggests that North America has been in the bandwagon in terms of generating demand for gene expression analysis. The region will retain its top position globally on account of the remarkable market of gene therapy. The market here is expected to gain significantly from solid investments flowing into genetic research, favourable government initiatives, and growing significance of NGS in the field of diagnostics. While the US continues to spearhead North American market for gene expression, China is at the forefront in Asia Pacific. China’s recombinant DNA technology landscape has been highly dynamic and will remain the key factor driving gene expression market in the region. Besides, the key Asian economies have been witnessing an exponentially rising rate of cancer prevalence over the past decade. The consequently expanding cancer research, and critically surging need for cancer therapeutics is thus likely to fuel growth of gene expression market across Asia Pacific. About Us
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness. Contact Fairfield Market Research London, UK UK +44 (0)20 30025888 USA (Toll-free) +1 (844) 3829746 Web: https://www.fairfieldmarketresearch.com/ Email: sales@fairfieldmarketresearch.com Follow Us: LinkedIn